New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareVialox vs Follistatin 315

Vialox vs Follistatin 315

Side-by-side comparison of key properties, dosing, and research.

Skin & CosmeticAnti-Aging & Longevity
Vialox
Anabolic & IGF
Follistatin 315
Summary
Vialox is a synthetic pentapeptide that mimics the activity of conotoxin from cone snails, acting as an antagonist of nicotinic acetylcholine receptors at the neuromuscular junction. Similar to Syn-Ake but derived from cone snail venom biochemistry, it reduces facial muscle contraction to smooth expression wrinkles.
Follistatin 315 is a splice variant isoform of follistatin produced by alternative mRNA processing. Unlike Follistatin 344 which is tethered to cell surfaces via heparan sulfate proteoglycans, FST-315 circulates freely in the bloodstream and has broader systemic distribution. It is the predominant circulating form and exerts systemic myostatin inhibition as well as FSH suppression, making it relevant to both muscle growth and reproductive endocrinology.
Half-Life
Not applicable (topical; effect duration hours)
~3–5 hours (longer systemic circulation vs FST-344)
Admin Route
Topical
SubQ, IM
Research
Typical Dose
0.005-0.05% in formulation
No established human dosing protocol
Frequency
Twice daily
Research use only
Key Benefits
  • Reduces dynamic wrinkles from repetitive facial expressions
  • Reversible muscle-relaxing effect without injection
  • Smooths forehead, periorbital, and perioral lines
  • Complementary to collagen-stimulating peptides
  • Well-studied tolerability in cosmetic concentrations
  • Can be combined with Syn-Ake for dual conotoxin/viper venom effect
  • Systemic myostatin inhibition for whole-body muscle growth
  • Freely circulating — broader tissue distribution than FST-344
  • Strong FSH-suppressive activity useful in certain hormonal protocols
  • Potential for greater anabolic effect across multiple muscle groups simultaneously
  • May be more relevant to reproductive endocrinology applications
  • Studied in gene therapy approaches for muscular dystrophy
Side Effects
  • Generally very well-tolerated topically
  • Rare contact sensitivity or mild irritation
  • No clinically significant systemic neuromuscular effects at cosmetic doses
  • Systemic FSH suppression — significant concern for fertility
  • Greater potential for off-target effects vs FST-344 due to systemic distribution
  • Limited human safety data
  • Potential cardiac hypertrophy with prolonged high-dose exposure
Stacks With